Skip to main content

Find a Clinical Trial

Filter

Services
Showing 1 - 4 out of 4
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
medical-cross
Bladder cancer
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Cancer Center
Learn more
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
medical-cross
Bladder cancer
user
All genders
person-wave 18-90
world
Recruiting now
info
Department of Urology
Learn more
BCL Study
medical-cross
Breast cancer
user
Female
person-wave 18+
world
Recruiting now
info
Department of Surgery
Learn more
TEE Assessment of PVR
medical-cross
Pulmonary vascular resistance
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Surgery, Division of Cardiac Surgery
Learn more
Jump back to top